Prosecution Insights
Last updated: October 04, 2026

Zhejiang Huakang Pharmaceutical Co. Ltd.

Technology area: Chemistry & Materials

3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days

Analysis

Zhejiang Huakang Pharmaceutical Co. Ltd. currently has 3 pending office actions in the Chemistry & Materials technology area. These actions are distributed among 3 distinct examiners, which suggests that the company is dealing with multiple individual perspectives at the patent office. The prosecution is focused within a distinct art unit, indicating a concentrated technical field for these applications. This concentration in a single art unit may allow for a more consistent procedural approach despite the involvement of multiple examiners.

JOSEPH W DRODGE is the busiest examiner for the company, currently responsible for 1 pending office action. This represents a portion of the total workload, as the other cases are handled by different individuals. The presence of 1 pending office action with the busiest examiner highlights the distributed nature of the portfolio. With all cases situated in the Chemistry & Materials sector, the company's legal strategy must account for the specific examination standards of that field. Managing multiple pending office actions across various examiners requires careful coordination to ensure that arguments made in one case do not negatively impact the others.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (33%)
0
Medium (0%)
2
Easy (67%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only2 (67%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
67% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DRODGE, JOSEPH W 1 78.2% +38.2%
LAU, JONATHAN S 1 63.7% -17.3%
MORENO, LARK JULIA 1 0.0% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18023836 SWEETENER LIQUID FOR PREVENTING AND RELIEVING INTESTINAL SUGAR ALCOHOL INTOLERANCE AND PREPARATION METHOD AND APPLICATION THEREOF MORENO, LARK JULIA 34d

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18655298 METHOD FOR CRYSTALLIZING COMPOUND SUGAR SOLUTION OF XYLOSE AND SUCROSE DRODGE, JOSEPH W —

Top Art Units

Art UnitApps
1793 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18655298 METHOD FOR CRYSTALLIZING COMPOUND SUGAR SOLUTION OF XYLOSE AND SUCROSE DRODGE, JOSEPH W — §112Other Non-Final OA — Pending May 05, 2024
18651633 METHODS FOR PREPARING HIGH-PURITY ARABINOSE CRYSTALS LAU, JONATHAN S — §112 Non-Final OA — Pending Apr 30, 2024
18023836 SWEETENER LIQUID FOR PREVENTING AND RELIEVING INTESTINAL SUGAR ALCOHOL INTOLERANCE AND PREPARATION METHOD AND APPLICATION THEREOF MORENO, LARK JULIA 1793 §103§112 Final Rejection 34d Pending Feb 28, 2023

Managing Zhejiang Huakang Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month